TR
EN
ORAL RETINOID TREATMENT IN A NEWBORN WITH LAMELLAR ICHTHYOSIS
Öz
Ichthyosis is a heterogeneous group of conification disorders characterized by hyperkeratosis involving the skin. One form of ichthyosis, lamellar ichthyosis (LI), is autosomal recessively inherited with an incidence of 1/300,000. The diagnosis is based on clinical findings, skin biopsy and genetic analysis. Treatment includes moisturizing the skin, reducing fluid loss and keratolytics. Oral retinoids have been found to be very successful in the treatment of LI(1). In this case, a premature newborn diagnosed with LI is presented because of its rarity and good response to oral retinoid treatment.
Anahtar Kelimeler
Destekleyen Kurum
yok
Kaynakça
- 1. Fischer J, Bourrat E. Genetics of Inherited Ichthyoses and Related Diseases. Acta Derm Venereol. 2020 ; 100(7):186-196.
- 2. Morelli JG. Disorders of keratinization. in: Kliegman RM, Behrman RE, Jenson HB, Stanton BF (eds). Nelson Textbook of Pediatrics. 18th edPhiladelphia: WB Sounders Company; 2007.p.2708-2714.
- 3 . Tekin M, Konca Ç, Kahramaner Z, ErdemirA. Harlequin iktiyozis: Aynı ailede üçüncü olgu. Türk Ped Arş 2014; 49: 269-71.
- 4. Soyuer U, Kurtoğlu S, Aktaş E, Hasanoğlu E. Hypernatremia in two collodion babies. Turk J Pediatr 1989; 31: 173-5.
- 5. Shibata, A. & Akiyama, M. Epidemiology, medical genetics, diagnosis and treatment of harlequin ichthyosis in Japan. Pediatr. Int. 2015;57, 516–22.
- 6. Lilly E, Bunick CG. Congenital Ichthyosis: A Practical Clinical Guide on Current Treatments and Future Perspectives. Clin Cosmet Investig Dermatol. 2023 ;11;16:2473-79.
Ayrıntılar
Birincil Dil
İngilizce
Konular
Dermatoloji
Bölüm
Olgu Sunumu
Yazarlar
Erken Görünüm Tarihi
19 Mayıs 2024
Yayımlanma Tarihi
31 Mayıs 2024
Gönderilme Tarihi
6 Mayıs 2024
Kabul Tarihi
17 Mayıs 2024
Yayımlandığı Sayı
Yıl 2024 Cilt: 14 Sayı: 3
APA
Sivas, H. M. (2024). ORAL RETINOID TREATMENT IN A NEWBORN WITH LAMELLAR ICHTHYOSIS. Journal of Contemporary Medicine, 14(3), 158-159. https://doi.org/10.16899/jcm.1478881
AMA
1.Sivas HM. ORAL RETINOID TREATMENT IN A NEWBORN WITH LAMELLAR ICHTHYOSIS. Journal of Contemporary Medicine. 2024;14(3):158-159. doi:10.16899/jcm.1478881
Chicago
Sivas, Hanife Merve. 2024. “ORAL RETINOID TREATMENT IN A NEWBORN WITH LAMELLAR ICHTHYOSIS”. Journal of Contemporary Medicine 14 (3): 158-59. https://doi.org/10.16899/jcm.1478881.
EndNote
Sivas HM (01 Mayıs 2024) ORAL RETINOID TREATMENT IN A NEWBORN WITH LAMELLAR ICHTHYOSIS. Journal of Contemporary Medicine 14 3 158–159.
IEEE
[1]H. M. Sivas, “ORAL RETINOID TREATMENT IN A NEWBORN WITH LAMELLAR ICHTHYOSIS”, Journal of Contemporary Medicine, c. 14, sy 3, ss. 158–159, May. 2024, doi: 10.16899/jcm.1478881.
ISNAD
Sivas, Hanife Merve. “ORAL RETINOID TREATMENT IN A NEWBORN WITH LAMELLAR ICHTHYOSIS”. Journal of Contemporary Medicine 14/3 (01 Mayıs 2024): 158-159. https://doi.org/10.16899/jcm.1478881.
JAMA
1.Sivas HM. ORAL RETINOID TREATMENT IN A NEWBORN WITH LAMELLAR ICHTHYOSIS. Journal of Contemporary Medicine. 2024;14:158–159.
MLA
Sivas, Hanife Merve. “ORAL RETINOID TREATMENT IN A NEWBORN WITH LAMELLAR ICHTHYOSIS”. Journal of Contemporary Medicine, c. 14, sy 3, Mayıs 2024, ss. 158-9, doi:10.16899/jcm.1478881.
Vancouver
1.Hanife Merve Sivas. ORAL RETINOID TREATMENT IN A NEWBORN WITH LAMELLAR ICHTHYOSIS. Journal of Contemporary Medicine. 01 Mayıs 2024;14(3):158-9. doi:10.16899/jcm.1478881